Omvoh 100 mg/mL (Mirikizumab-Mrkz INJECTION, SOLUTION) 100 mg/mL

Omvoh 100 mg/mL is a subcutaneous injection solution containing mirikizumab-mrkz. This medication is used to manage specific inflammatory conditions. Learn more about its uses and effects.

Strength

100 mg/mL

Pack Size

2 SYRINGE in 1 CARTON (0002-8011-61) / 1 mL in 1 SYRINGE

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Omvoh 100 mg/mL is primarily used for the treatment of moderate to severe plaque psoriasis. This medication targets specific proteins involved in the inflammatory process, helping to reduce symptoms. What is Omvoh used for? It is often prescribed for conditions where inflammation plays a key role, aiming to improve quality of life for patients.

Side Effects

Common effects of Omvoh 100 mg/mL may include redness or itching at the injection site. Some users might experience fatigue or mild headaches. These effects are generally temporary and vary among individuals. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Omvoh 100 mg/mL should be stored at room temperature and protected from light. It is important to follow proper injection techniques to minimize the risk of infection. Patients with a history of allergic reactions to mirikizumab-mrkz should avoid using this medication.

Avoid Interactions

Omvoh 100 mg/mL may interact with other medications, including those that suppress the immune system. It is advisable to inform your healthcare provider about all current medications to avoid potential interactions. Alcohol consumption should be moderated while using this medication.

Frequently Asked Questions

Omvoh 100 mg/mL is used to treat moderate to severe plaque psoriasis by targeting inflammation.

Omvoh 100 mg/mL is administered subcutaneously, typically by a healthcare professional or as directed.

Common side effects may include redness at the injection site, fatigue, and mild headaches.

Omvoh 100 mg/mL may interact with other medications, so it is important to consult a healthcare provider.

Omvoh 100 mg/mL should be stored at room temperature and protected from light.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.